Xueyi Skin Care Sunscreen Cream
NDC Package 84753-037-01
Package Information
Xueyi Skin Care Sunscreen (sunscreen) cream is uSES:- Helps prevent sunburn. This formulation utilizes a cream delivery system. Marketed by Guangdong Bisutang Biotechnology Co., Ltd, this product is identified by NDC 84753-037 and is authorized under FDA application 505G(a)(3).
Identification & Billing
Clinical Specifications
- 4-METHYLBENZYLIDENE CAMPHOR 2 mg/100g
- ETHYLHEXYL METHOXYCINNAMATE 5.9958 mg/100g
- HONEY .001 mg/100g
- HYDROLYSED MARINE COLLAGEN (ENZYMATIC .01 mg/100g
- 2000 MW) .75 mg/100g
- METHYLENE BIS-BENZOTRIAZOLYL TETRAMETHYLBUTYLPHENOL 3 mg/100g
- OCTOCRYLENE 1 mg/100g
- PHENYLBENZIMIDAZOLE SULFONIC ACID .00885 mg/100g
- SACCHAROMYCES LYSATE
Regulatory & Marketing
Hierarchy Structure
- 84753 - Guangdong Bisutang Biotechnology Co., Ltd
- 84753-037 - Xueyi Skin Care Sunscreen
- 84753-037-01 - 48 g in 1 BOTTLE
- 84753-037 - Xueyi Skin Care Sunscreen
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 84753-037-01 identifies a specific commercial package of 48 g in 1 bottle of Xueyi Skin Care Sunscreen, a human over the counter drug labeled by Guangdong Bisutang Biotechnology Co., Ltd. This cream is formulated for topical use and contains 4-methylbenzylidene camphor; ethylhexyl methoxycinnamate; honey; hydrolysed marine collagen (enzymatic; 2000 mw); methylene bis-benzotriazolyl tetramethylbutylphenol; octocrylene; phenylbenzimidazole sulfonic acid; saccharomyces lysate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Guangdong Bisutang Biotechnology Co., Ltd on September 22, 2025. The current certification is valid through December 31, 2026.
How is this Guangdong Bisutang Biotechnology Co., Ltd product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 84753003701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.